A detailed history of Fairman Group, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Fairman Group, LLC holds 3,197 shares of PFE stock, worth $79,285. This represents 0.08% of its overall portfolio holdings.

Number of Shares
3,197
Previous 3,186 0.35%
Holding current value
$79,285
Previous $89.1 Million 3.78%
% of portfolio
0.08%
Previous 0.09%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 22, 2024

BUY
$27.7 - $31.39 $304 - $345
11 Added 0.35%
3,197 $92.5 Million
Q2 2024

Jul 29, 2024

BUY
$25.26 - $29.6 $277 - $325
11 Added 0.35%
3,186 $89.1 Million
Q1 2024

Apr 30, 2024

BUY
$25.89 - $29.73 $7,042 - $8,086
272 Added 9.37%
3,175 $88.1 Million
Q4 2023

Mar 26, 2024

BUY
$26.13 - $33.94 $75,855 - $98,527
2,903 New
2,903 $83.6 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $139B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Fairman Group, LLC Portfolio

Follow Fairman Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fairman Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fairman Group, LLC with notifications on news.